Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Policy Forum
Submitted on May 4, 2005 Issues in Oocyte Donation for Stem Cell Research
1 Stanford Center for Biomedical Ethics and Department of Pediatrics, Stanford University, Palo Alto, CA 94304, USA. * To whom correspondence should be addressed.
As described by Hwang et al. in this issue (1), somatic cell nuclear transfer (SCNT) to create human embryonic stem cell (hESC) lines represents a step towards realizing the promise of stem cell research. They have shown the generalizability and efficiency of the approach in creating 11 cell lines from the nuclei of skin cells of individuals with serious diseases or disabilities and the oocytes of donors. This work raises ethical and policy questions for hESC researchers. As hESC research proceeds internationally, these issues must be adequately addressed for public confidence to be maintained. We will discuss three issues here that particularly deserve attention: (i) ethical oversight of research collaborations between scientists working in countries with different standards, (ii) protection of oocyte donors, and (iii) avoidance of unrealistic expectations (therapeutic misconception).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science. ISSN 0036-8075 (print), 1095-9203 (online)